- Report
- October 2023
- 78 Pages
Ireland
From €3053EUR$3,500USD£2,661GBP
- Report
- October 2023
- 174 Pages
Global
From €3925EUR$4,500USD£3,421GBP
- Report
- October 2023
- 77 Pages
Canada
From €3053EUR$3,500USD£2,661GBP
- Report
- October 2023
- 82 Pages
Malaysia
From €3053EUR$3,500USD£2,661GBP
- Report
- September 2023
- 72 Pages
Israel
From €3053EUR$3,500USD£2,661GBP
- Report
- September 2023
- 70 Pages
Israel
From €3053EUR$3,500USD£2,661GBP
- Report
- August 2023
- 77 Pages
Egypt
From €3053EUR$3,500USD£2,661GBP
From €3053EUR$3,500USD£2,661GBP
From €3053EUR$3,500USD£2,661GBP
- Report
- January 2023
- 299 Pages
Global
From €4361EUR$5,000USD£3,801GBP
- Report
- February 2025
- 200 Pages
Global
From €3916EUR$4,490USD£3,413GBP
- Report
- January 2024
- 200 Pages
Global
From €4361EUR$5,000USD£3,801GBP
- Report
- December 2024
- 200 Pages
Global
From €3271EUR$3,750USD£2,851GBP
- Report
- December 2024
- 200 Pages
Global
From €3271EUR$3,750USD£2,851GBP
- Report
- October 2024
- 200 Pages
Global
From €3271EUR$3,750USD£2,851GBP
- Report
- May 2024
- 200 Pages
Global
From €3620EUR$4,150USD£3,155GBP
- Report
- March 2024
- 200 Pages
Global
From €3620EUR$4,150USD£3,155GBP
- Report
- March 2024
- 200 Pages
Global
From €3620EUR$4,150USD£3,155GBP
- Report
- October 2023
- 145 Pages
Global
From €2748EUR$3,150USD£2,395GBP
- Report
- August 2023
- 145 Pages
Global
From €2748EUR$3,150USD£2,395GBP

The Continuous Glucose Monitoring (CGM) market is a subset of the larger glucose testing market. CGM is a technology that allows for the continuous monitoring of glucose levels in the body. It is typically used by people with diabetes to help them better manage their condition. CGM systems consist of a sensor, transmitter, and receiver. The sensor is inserted under the skin and measures glucose levels in the interstitial fluid. The transmitter sends the data to the receiver, which displays the glucose levels. CGM systems can provide real-time data and alert users when their glucose levels are too high or too low.
Some companies in the CGM market include Dexcom, Abbott, Medtronic, and Senseonics. Show Less Read more